Another biomarker of importance in NHL is VEGFR-2, a protein that makes up receptor tyrosine kinase (RTK), has a role in the formation of new blood vessels (angiogenesis) and is reported to be a potential target for the suppression of cancer growth and metastasis. This evidence concerns the gene NTRK1 and non-Hodgkin lymphoma.